Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Journal:
Current Neurovascular Research
Volume:
11
Page:
107-113
Author(s):
Hong You, Ting Li, Jinnan Zhang, Qiang Lei, Xi Tao, Pinghui Xie and Wei Lu
Toll-Like Receptors in Human Multiple Myeloma: New Insight into Inflammation-Related Pathogenesis
Journal:
Current Molecular Medicine
Volume:
14
Page:
423-431
Author(s):
J. Abdi, J. Garssen and F. Redegeld
α-Methylene-γ-lactones as a Novel Class of Anti-leukemic Agents
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
688-694
Author(s):
Katarzyna Gach and Anna Janecka
New Drugs for Follicular Lymphoma in Older Adults
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
657-664
Author(s):
Anna Schmitt and Pierre Soubeyran
Statins and Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
706-712
Author(s):
Natalia G. Vallianou, Alexandra Kostantinou, Marios Kougias and Christos Kazazis
Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
673-687
Author(s):
Jian-Feng Tang, Qing Wen, Jian Sun, Wei-Ming Zhang and Hai-Liang Zhu
Natural Products, Synthetic and Non-Nucleoside Compounds as Inhibitors of Enzymes Related to DNA: Update 2013
Journal:
Current Enzyme Inhibition
Volume:
10
Page:
13-38
Author(s):
Carlos R. Pungitore
Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
9
Page:
153-175
Author(s):
Jo-Anne de la Mare, Lara Contu, Morgan C. Hunter, Buhle Moyo, Jason N. Sterrenberg, Karim C.H. Dhanani, Lorraine Z. Mutsvunguma and Adrienne L. Edkins
Tubulin Inhibitors: A Patent Survey
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
9
Page:
176-220
Author(s):
Kunal Nepali, Ritu Ojha, Sahil Sharma, Preet M.S. Bedi and Kanaya L. Dhar
Synthesis and Anticancer Activity of Some 2-[3/4-(2-Substituted Phenyl-2- oxoethoxy)benzylidene]-6-substituted-2,3-dihydro-1H-inden-1-one Derivatives
Journal:
Letters in Drug Design & Discovery
Volume:
11
Page:
578-585
Author(s):
Nalan Gundogdu-Karaburun, Ahmet Cagri Karaburun, Seref Demirayak, Ismail Kayagil and Leyla Yurttas